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Abstract: Biliary complications following liver transplantations, with leaks and bile duct strictures being
the most common ones, are greatly feared. Portobiliary fistulas are rare, but may cause potentially
life-threatening complications. The presented case shows the first successful treatment of a portobiliary
fistula by an endoscopically deployed fully covered self-expandable metal stent after liver transplantation.
In accordance to the already established use in refractory bile leaks, we believe that fully covered self-
expandable metal stent is a safe and efficient treatment option for portobiliary fistula.
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ABSTRACT
Biliary complications following liver transplantations, with leaks and bile duct strictures being the most common ones, are greatly
feared. Portobiliary ﬁstulas are rare, but may cause potentially life-threatening complications. The presented case shows the ﬁrst
successful treatment of a portobiliary ﬁstula by an endoscopically deployed fully covered self-expandable metal stent after liver
transplantation. In accordance to the already established use in refractory bile leaks, we believe that fully covered self-expandable
metal stent is a safe and efﬁcient treatment option for portobiliary ﬁstula.
INTRODUCTION
To date, only 2 cases of portobiliary ﬁstulas after liver transplantation (LT) and only 6 cases related to endoscopic retrograde
cholangiopancreatography (ERCP) have been reported in the literature.1 The etiologies range from iatrogenic injuries to hep-
atobiliary pathologies (eg, cholangitis and stone erosion) butmay also be caused by recurrent or chronic inﬂammatory processes and
vascular pathologies.2 To our knowledge, this is the ﬁrst reported case of a portobiliary ﬁstula in a liver transplant recipient treated
with endoscopically deployed biliary fully covered self-expandable metal stent (FCSEMS).
CASE REPORT
A 60-year-old woman with hepatitis C-related cirrhosis complicated by recurrent hepatic encephalopathies and chronic portal vein
thrombosis underwent LT with construction of an end-to-side anastomosis of the donor portal vein to the superior mesenteric vein
and an end-to-end bile duct anastomosis in common technique. Because of massive venous bleeding from local varices during
preparation of the recipient’s hepatic artery, an iliac conduit was constructed instead. The patient recovered well after surgery with
normal liver graft function.
Fivemonths after LT, stenosis of the bile duct anastomosis with biliary leakage causing elevated liver enzymes in a cholestatic pattern
was treatedwith a pigtail. Six weeks later, a FCSCEMSwas inserted because of persisting leakage with no further signs of leakage after
stent extraction 3 months later. The further clinical course was complicated by hepatitis C reinfection and recurrent stenosis of the
biliary anastomosis, repeatedly treated with ERCP. In a total of 10 ERCPs, 3 balloon dilatations, 4 placements of a total of 7 pigtails,
and 2 stent placementswere conducted. In addition, because of biopsy-proven signiﬁcantﬁbrosis (METAVIR F3, Ishak 4) 12months
after LT, the patient was successfully treated with pegylated interferon and ribavirin over a period of 50 weeks.
Thirty-four months after LT and 29months after the ﬁrst ERCP, the patient was scheduled for an elective ERCP (#11) for biliary pigtail
exchange.After recovery of 3 plastic double-pigtails, cholangiogramrevealed a large portobiliaryﬁstula at the site of the anastomosiswith
slight hemobilia from the papilla. During the same intervention, the decisionwasmade to place a FCSEMS inside the bile duct to seal the
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leak. Consequently, a 10-mm-diameter and 4-cm-long fully
covered self-expandable metal stent (FCSEMS) (Hanarostent
Biliary Flap CCC; M.I. Tech Co., Ltd, South Korea) was placed
with no evidence of further leakage in the subsequent cholan-
giogram and ceasing of hemobilia (Figure 1). Prophylactic anti-
biotic treatment with ciproﬂoxacin was established.
Forty-eight hours later, the patient presented with signs of
septic shock and was admitted to the intensive care unit for
hemodynamic support and empiric broad-spectrum antibiotic
treatment (piperacillin and tazobactam). Computed tomogra-
phy and subsequent angiography showed no evidence of per-
sistent ﬁstula, but revealed a chronic obliteration of the iliac
conduit with partial perfusion of the hepatic artery by gastro-
duodenal collaterals. Because of anuric kidney failure, contin-
uous venovenous hemoﬁltration was necessary for 4 days,
followed by intermittent hemodialysis over the period of 1
month. Eventually, the patient recovered well and an evaluation
for liver re-transplantation to treat the portobiliary ﬁstula was
discussed.
Four months later, the patient was scheduled for FCSEMS re-
placement (ERCP #12). Surprisingly, after extraction of the lying
FCSEMS no evidence of persisting leakage on cholangiogram and
no relevant stenosis was found (Figure 2). During the 50-month
follow-up, no evidence of recurrent stenosis or portobiliary ﬁstula
was found, making no further endoscopic intervention necessary.
DISCUSSION
As presented, portobiliary ﬁstulas may cause potentially life-
threatening complications like cholangiosepsis. In other cases,
hemobilia with anemia, elevated liver enzymes, or abdominal
pain might be the leading clinical sign. Given the rarity of these
ﬁstulas, the recognition of clinical signs, or rather the awareness
of the possibility of portobiliary ﬁstulas in patients having un-
dergone surgical and/or endoscopic interventions in close
proximity of the biliary structures is of utmost importance.
Hence, a detailed history taking regarding procedures involving
biliary structures is essential in the case of the abovementioned
clinical signs.
Figure1.Cholangiogramat diagnosis. (A) Cholangiogramwith contrast in the commonand intrahepatic bile duct andwithin the left portal vein
(arrows; visually almost corresponding with a regular portography). (B) Closure of the fistula by fully covered self-expandable metal stent
(arrows: proximal and distal end of the stent).
Figure 2. Follow-up cholangiogram. (A) Fully covered self-expandable metal stent (arrows: proximal and distal end of the stent) in situ. (B)
Cholangiogram after stent removal without signs of fistula or stenosis.
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Possible treatment strategies include medical management,
balloon tamponade, coil embolization, percutaneous or trans-
jugular stent placements, and surgical repair.1 In addition, So
et al reported a successful treatment of a portobiliary ﬁstulawith
a FCSEMS.3 In their case, the ﬁstula, caused by a biliary stent for
management of obstructive jaundice in a palliative setting in
a patient diagnosed with hepatocellular carcinoma, led to re-
current bacteremia and upper gastrointestinal bleeding.
In a recent review, Roos et al considered biliary complications
“to be theAchilles’ heel of LT”with leaks and bile duct strictures
being themost common ones. Bile duct leaks after duct-to-duct
anastomosis are usually treated endoscopically by plastic stent
insertion.4However, in refractory cases or larger leaks, FCSEMS
is frequently used.4 In their review, the authors did not address
on the treatment of portobiliary ﬁstulas, most likely because of
the very low prevalence.
Regarding the abovementioned, ERCP in general and the use of
FCSEMS in speciﬁc has been shown to be effective and safe in
the treatment of biliary complications after LT. As discussed
previously, we believe that an advantage of ERCP over percu-
taneous procedures is the use of natural oriﬁces and the pos-
sibility to visualize the bile duct before starting the intervention
resulting in increased patient safety.4 In addition, the compli-
cation ratio of ERCP, even if multiple interventions are neces-
sary, is favorable compared with those of surgical interventions
like hepatico-jejunostomy.4
The use of FCSEMS in the presented case resulted in a quick and
complication-free closure of the ﬁstula. The shown technique is
unique because the stenting was conducted in the “low pressure
zone” within the bile duct, not in the portal vessel. The ad-
vantage of the chosen approach is 2-fold. First, diagnosis of the
ﬁstula and its treatment were possible within 1 therapeutic
procedure without the need of further delay. Second, the portal
vein, representing the most important hepatic vascular struc-
ture providing 70% of the blood supply, was neither injured nor
embolized. Especially in this patient with previously unknown
obliteration of the iliac conduit, an obliteration of the portal
vein could have been fatal.
In summary, the presented case shows the ﬁrst successful
treatment of a portobiliary ﬁstula by endoscopically deployed
FCSEMS after LT. In accordance with the already established
use in refractory bile leaks, we believe that FCSEMS resembles
a safe and efﬁcient treatment option for portobiliary ﬁstula.
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